Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (1-10 of 403) with videos related to

Pageof 41
Sort By:
Human Vaccines & Immunotherapeutics|June 5, 2013
The evidence for use of pneumococcal conjugate over polysaccharide in childrenRay Borrow
Travel Medicine and Infectious Disease|September 1, 2009
Meningococcal disease and prevention at the HajjRay Borrow
Tropical Medicine & International Health : TM & IH|September 6, 2012
Advances with vaccination against Neisseria meningitidisRay Borrow
Expert Review of Vaccines|March 26, 2011
Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccinesJan Poolman, Ray Borrow
Expert Review of Vaccines|February 6, 2004
Serologic correlates of protection for evaluating the response to meningococcal vaccinesPaul Balmer, Ray Borrow
Expert Review of Vaccines|October 7, 2010
Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccineXilian Bai, Ray Borrow
Expert Review of Vaccines|December 23, 2006
Long-term protection in children with meningococcal C conjugate vaccination: lessons learnedRay Borrow, Elizabeth Miller
Advances in Therapy|May 29, 2013
Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TTHelen Findlow, Ray Borrow
Pathogens and Disease|March 24, 2017
Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?Jamie Findlow, Ray Borrow
Expert Review of Vaccines|March 22, 2024
The important lessons lurking in the history of meningococcal epidemiologyRay Borrow, Jamie Findlow
Pageof 41

Showing results (1-10 of 403) with videos related to

Sort By:
Pageof 41
Human Vaccines & Immunotherapeutics|June 5, 2013
The evidence for use of pneumococcal conjugate over polysaccharide in childrenRay Borrow
Travel Medicine and Infectious Disease|September 1, 2009
Meningococcal disease and prevention at the HajjRay Borrow
Tropical Medicine & International Health : TM & IH|September 6, 2012
Advances with vaccination against Neisseria meningitidisRay Borrow
Expert Review of Vaccines|March 26, 2011
Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccinesJan Poolman, Ray Borrow
Expert Review of Vaccines|February 6, 2004
Serologic correlates of protection for evaluating the response to meningococcal vaccinesPaul Balmer, Ray Borrow
Expert Review of Vaccines|October 7, 2010
Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccineXilian Bai, Ray Borrow
Expert Review of Vaccines|December 23, 2006
Long-term protection in children with meningococcal C conjugate vaccination: lessons learnedRay Borrow, Elizabeth Miller
Advances in Therapy|May 29, 2013
Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TTHelen Findlow, Ray Borrow
Pathogens and Disease|March 24, 2017
Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?Jamie Findlow, Ray Borrow
Expert Review of Vaccines|March 22, 2024
The important lessons lurking in the history of meningococcal epidemiologyRay Borrow, Jamie Findlow
Pageof 41